Amphastar Pharmaceuticals (AMPH) Invested Capital (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly Invested Capital of $1.7 million for Q1 2026, up 645.98% year-over-year from $224000.0 in Q1 2025, and up 1.83% quarter-over-quarter from $1.6 million in Q4 2025.
Amphastar Pharmaceuticals (AMPH) Invested Capital (2013 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Invested Capital history runs 14 years deep, the most recent figure standing at $1.7 million for Q1 2026.
- In Q1 2026, Invested Capital rose 645.98% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $5.2 million (up 438.27% YoY), while the FY2025 annual figure was $1.6 million, up 601.28% from the prior year.
- Invested Capital for Q1 2026 stood at $1.7 million, up from $1.6 million in the prior quarter.
- The five-year high for Invested Capital was $12.9 million in Q2 2023, with the low at $224000.0 in Q1 2025.
- The 5-year median for Invested Capital is $927000.0 (2025), against an average of $1.8 million.
- The sharpest annual moves came in 2024 and 2026: Invested Capital slumped 98.07% in 2024, then surged 645.98% in 2026.
- Amphastar Pharmaceuticals' Invested Capital stood at $3.0 million in 2022, then plunged by 85.69% to $436000.0 in 2023, then tumbled by 46.33% to $234000.0 in 2024, then surged by 601.28% to $1.6 million in 2025, then gained by 1.83% to $1.7 million in 2026.
- Business Quant data shows AMPH's Invested Capital at $1.7 million in Q1 2026, $1.6 million in Q4 2025, and $923000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | 9.90 Bn |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 4.50 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 3.74 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.74 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 73.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 630.00 Mn |
| 10 | Amphastar Pharmaceuticals | 942.71 Mn | 652.59 Mn | 93.47 Mn | 2.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.49 Mn |
| Mar 31, 2026 | 1.67 Mn |
| Dec 31, 2025 | 1.64 Mn |
| Sep 30, 2025 | 923,000.00 |
| Jun 30, 2025 | 927,000.00 |
| Mar 31, 2025 | 224,000.00 |
| Dec 31, 2024 | 234,000.00 |
| Sep 30, 2024 | 252,000.00 |
| Jun 30, 2024 | 249,000.00 |
| Mar 31, 2024 | 428,000.00 |
| Dec 31, 2023 | 436,000.00 |
| Sep 30, 2023 | 433,000.00 |
| Jun 30, 2023 | 12.92 Mn |
| Mar 31, 2023 | 2.17 Mn |
| Dec 31, 2022 | 3.05 Mn |
| Sep 30, 2022 | 1.68 Mn |
| Jun 30, 2022 | 2.06 Mn |
| Mar 31, 2022 | 2.16 Mn |
| Dec 31, 2021 | 2.20 Mn |
| Sep 30, 2021 | 2.26 Mn |